Demo Data from SIGIR 2026 / reviewers in the wild / expert
Muhammad Tahir Ul Qamar
dblp:251/2897
· DBLP profile ↗
2ranked-venue papers
1as first author
1since 2021 · last 2023
0000-0003-4832-4250ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 1 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
genomics |
0.4 | 1 | 2019 | ppsPCP: a plant presence/absence variants scanner and pan-genome construction pipeline · Bioinform. 2019 |
Bioinformatics and computational biology › genomics
plant genomics |
0.1 | 1 | 2019 | ppsPCP: a plant presence/absence variants scanner and pan-genome construction pipeline · Bioinform. 2019 |
Methods — techniques the papers use, named apart from their topics
sequence annotation · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2023 | Machine learning for synergistic network pharmacology: a comprehensive overviewabstractNetwork pharmacology is an emerging area of systematic drug research that attempts to understand drug actions and interactions with multiple targets. Network pharmacology has changed the paradigm from 'one-target one-drug' to highly potent 'multi-target drug'. Despite that, this synergistic approach is currently facing many challenges particularly mining effective information such as drug targets, mechanism of action, and drug and organism interaction from massive, heterogeneous data. To overcome bottlenecks in multi-target drug discovery, computational algorithms are highly welcomed by scientific community. Machine learning (ML) and especially its subfield deep learning (DL) have seen impressive advances. Techniques developed within these fields are now able to analyze and learn from huge amounts of data in disparate formats. In terms of network pharmacology, ML can improve discovery and decision making from big data. Opportunities to apply ML occur in all stages of network pharmacology research. Examples include screening of biologically active small molecules, target identification, metabolic pathways identification, protein-protein interaction network analysis, hub gene analysis and finding binding affinity between compounds and target proteins. This review summarizes the premier algorithmic concepts of ML in network pharmacology and forecasts future opportunities, potential applications as well as several remaining challenges of implementing ML in network pharmacology. To our knowledge, this study provides the first comprehensive assessment of ML approaches in network pharmacology, and we hope that it encourages additional efforts toward the development and acceptance of network pharmacology in the pharmaceutical industry. Fatima Noor, Usman Ali Ashfaq, Muhammad Tahir Ul Qamar |
Briefings Bioinform. | 5 |
| 2019 | ppsPCP: a plant presence/absence variants scanner and pan-genome construction pipelineabstractSUMMARY: Since the idea of pan-genomics emerged several tools and pipelines have been introduced for prokaryotic pan-genomics. However, not a single comprehensive pipeline has been reported which could overcome multiple challenges associated with eukaryotic pan-genomics. To aid the eukaryotic pan-genomic studies, here we present ppsPCP pipeline which is designed for eukaryotes especially for plants. It is capable of scanning presence/absence variants (PAVs) and constructing a fully annotated pan-genome. We believe with these unique features of PAV scanning and building a pan-genome together with its annotation, ppsPCP will be useful for plant pan-genomic studies and aid researchers to study genetic/phenotypic variations and genomic diversity. AVAILABILITY AND IMPLEMENTATION: The ppsPCP is freely available at github DOI: https://doi.org/10.5281/zenodo.2567390 and webpage http://cbi.hzau.edu.cn/ppsPCP/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Muhammad Tahir Ul Qamar, Xitong Zhu, Feng Xing, Ling-Ling Chen |
Bioinform. | 1 |